Oligodendrogliomas Completed Phase 2 Trials for Everolimus (DB01590)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00823459Phase II Trial of RAD001 in Patients With Recurrent Low Grade GliomaTreatment